Congress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment in type 1 diabetes (T1D) research. The legislation now heads to the President’s desk to be signed into law, ensuring continued momentum toward better treatments, disease-modifying therapies, and cures. This legislation: Extends the SDP through December 31, 2026, and increases funding from $160 million to $200 million annually.
Anton S. Becker
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Anton S.
Contact Anton S., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack